PMID: 7542305Jul 1, 1995Paper

Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria

Journal of Leukocyte Biology
B C AhvaziMary M Stevenson

Abstract

Examination of the proliferative responses in vitro to mitogens (concanavalin A, phytohemagglutinin, lipopolysaccharide) of spleen cells recovered from C57BL/6 mice during blood-stage Plasmodium chabaudi AS infection revealed that the most severe suppression occurred during the first 14 days post infection, that is, during the acute phase of infection. Coincidently, inducible nitric oxide synthase gene expression was found to be up-regulated in the spleens of infected mice, and both splenic and peritoneal macrophages produced high levels of NO in vitro in response to stimulation with lipopolysaccharide (LPS). The roles of NO, a molecule recently found to mediate immunosuppression during parasitic infections, and of the well-recognized immunosuppressive molecule prostaglandin were, therefore, investigated in the suppression of proliferation to mitogens and specific antigen of spleen cells from 7- and 14-day P. chabaudi AS-infected mice. Addition of either 0.5 mM NG-monomethyl-L-arginine (L-NMMA) or 0.5 mM aminoguanidine (AG), inhibitors of NO synthase, or 10 micrograms/ml indomethacin (INDO), a prostaglandin inhibitor, partially but significantly abrogated the suppression in response to concanavalin A (Con A) and phytohemaggluti...Continue Reading

Citations

Dec 1, 1996·Immunology and Cell Biology·L Schofield, S D Tachado
Mar 11, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Floriana BerrettaMary M Stevenson
Jul 21, 1998·Annals of the New York Academy of Sciences·W L GoffC W Cluff
Dec 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Courtney L MeierPaul M Kaye
Jun 3, 2008·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Ayako MabuchiAntony M Wheatley
Nov 10, 2010·European Journal of Immunology·Jo A Van GinderachterGeert Raes
Jan 1, 1997·Annual Review of Immunology·J MacMickingC Nathan
May 16, 2002·Infection and Immunity·James LuyendykAnne C Avery
Jul 20, 2004·Clinical Microbiology Reviews·Ian A ClarkWilliam B Cowden
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·H C van der HeydeM B Grisham
Jan 23, 2003·The Journal of Experimental Medicine·Carlos Ocaña-MorgnerAna Rodriguez
Apr 10, 2014·Immunological Reviews·John R GraingerYasmine Belkaid
Dec 17, 2009·Immunopharmacology and Immunotoxicology·Neha Mittal, Sankar Nath Sanyal
Jun 12, 2002·Genes and Immunity·A FortinP Gros
Dec 3, 1999·Parasite Immunology·T ScorzaP De Baetselier
Dec 12, 1997·International Journal for Parasitology·I A ClarkL S Jacobson
Jul 26, 2011·Journal of Neuroinflammation·Jeroen F J BogieJerome J A Hendriks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.